<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
                      "http://www.w3.org/TR/REC-html40/loose.dtd">
<html>
<head>
<title>extropians: ALT-711</title>
<meta name="Author" content="Technotranscendence (neptune@mars.superlink.net)">
<meta name="Subject" content="ALT-711">
</head>
<body bgcolor="#FFFFFF" text="#000000">
<h1>ALT-711</h1>
<!-- received="Fri Jul 20 17:58:34 2001" -->
<!-- isoreceived="20010720235834" -->
<!-- sent="Fri, 20 Jul 2001 20:04:56 -0700" -->
<!-- isosent="20010721030456" -->
<!-- name="Technotranscendence" -->
<!-- email="neptune@mars.superlink.net" -->
<!-- subject="ALT-711" -->
<!-- id="013301c11191$ed25eba0$a387ecd1@neptune" -->
<strong>From:</strong> Technotranscendence (<a href="mailto:neptune@mars.superlink.net?Subject=Re:%20ALT-711&In-Reply-To=&lt;013301c11191$ed25eba0$a387ecd1@neptune&gt;"><em>neptune@mars.superlink.net</em></a>)<br>
<strong>Date:</strong> Fri Jul 20 2001 - 21:04:56 MDT
<p>
<!-- next="start" -->
<ul>
<li><strong>Next message:</strong> <a href="1586.html">Party of Citizens: "Re: The Doctrine of Pope Asimov I"</a>
<li><strong>Previous message:</strong> <a href="1584.html">Lee Corbin: "RE: privacy/openness"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#1585">[ date ]</a>
<a href="index.html#1585">[ thread ]</a>
<a href="subject.html#1585">[ subject ]</a>
<a href="author.html#1585">[ author ]</a>
</ul>
<hr noshade><p>
<!-- body="start" -->
<p>
A while back on this list, someone had mentioned the drug ALT-711 in regards
<br>
to reversing glycation -- a process whereby glucose (a sugar) bund to
<br>
proteins to create stiff formations in, well, just about all of the body.
<br>
The stiff formations are pretty permanent and lead to all sorts of nasty
<br>
effects, including stiffness in heart muscle, skin wrinkles, and loss of
<br>
flexibility in blood vessels.  ALT-711 breaks these down.  To my knowledge,
<br>
there's currently nothing else that undoes this kind of damage.
<br>
<p>I've just read in the current issue of _Life Extension_ -- August 2001, not
<br>
yet online -- that Alteon, Inc., the maker of ALT-711, is now starting Phase
<br>
IIb trials.  (Also, and as many might have guessed, the drug passed Phase I
<br>
and Phase IIa trials.  In fact, results of the latter were presented in
<br>
March of this year.)
<br>
<p>Anyhow, I think this is very good new.
<br>
<p>_Life Extension_ is online at <a href="http://www.lef.org/magazine/mag_all.html">http://www.lef.org/magazine/mag_all.html</a>
<br>
<p>Alteon, Inc. is online at <a href="http://alteonpharma.com/">http://alteonpharma.com/</a>
<br>
<p>Happily,
<br>
<p>Daniel Ust
<br>
<a href="http://uweb.superlink.net/neptune/">http://uweb.superlink.net/neptune/</a>
<br>
&nbsp;&nbsp;&nbsp;&nbsp;See me singlehandedly defeat pancritical rationalism at:
<br>
<a href="http://uweb.superlink.net/neptune/PCR.html">http://uweb.superlink.net/neptune/PCR.html</a>
<br>
<p><!-- body="end" -->
<hr noshade>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="1586.html">Party of Citizens: "Re: The Doctrine of Pope Asimov I"</a>
<li><strong>Previous message:</strong> <a href="1584.html">Lee Corbin: "RE: privacy/openness"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#1585">[ date ]</a>
<a href="index.html#1585">[ thread ]</a>
<a href="subject.html#1585">[ subject ]</a>
<a href="author.html#1585">[ author ]</a>
</ul>
<!-- trailer="footer" -->
<hr noshade>
<p>
<small>
<em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2b30</a> 
: <em>Fri Oct 12 2001 - 14:39:50 MDT</em>
</em>
</small>
</body>
</html>
